Cellectar Biosciences (CLRB) Beats Q4 Earnings Estimates by $0.68
Cellectar Biosciences (NASDAQ:CLRB) reported quarterly earnings results on March 04, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Read more
